Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124208872 | 12420887 | 2 | F | 20160726 | 20160531 | 20160803 | EXP | US-JAZZ-2015-US-016811 | JAZZ | 0.00 | M | Y | 90.70000 | KG | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124208872 | 12420887 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 124208872 | 12420887 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 124208872 | 12420887 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 124208872 | 12420887 | 4 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | UNK | U | 0 | SPRAY | |||||||||
| 124208872 | 12420887 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | U | 0 | TABLET | |||||||||
| 124208872 | 12420887 | 6 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 124208872 | 12420887 | 7 | C | CYPROHEPTADINE. | CYPROHEPTADINE | 1 | UNK | U | 0 | TABLET | |||||||||
| 124208872 | 12420887 | 8 | C | Multivitamins w/minerals | MINERALSVITAMINS | 1 | UNK | U | 0 | TABLET | |||||||||
| 124208872 | 12420887 | 9 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 124208872 | 12420887 | 10 | C | UROXATRAL | ALFUZOSIN HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 124208872 | 12420887 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124208872 | 12420887 | 1 | Insomnia |
| 124208872 | 12420887 | 4 | Product used for unknown indication |
| 124208872 | 12420887 | 5 | Product used for unknown indication |
| 124208872 | 12420887 | 6 | Product used for unknown indication |
| 124208872 | 12420887 | 7 | Product used for unknown indication |
| 124208872 | 12420887 | 8 | Product used for unknown indication |
| 124208872 | 12420887 | 9 | Product used for unknown indication |
| 124208872 | 12420887 | 10 | Product used for unknown indication |
| 124208872 | 12420887 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124208872 | 12420887 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124208872 | 12420887 | Condition aggravated | |
| 124208872 | 12420887 | Pre-existing condition improved | |
| 124208872 | 12420887 | Sleep apnoea syndrome | |
| 124208872 | 12420887 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124208872 | 12420887 | 1 | 200801 | 200801 | 0 | |
| 124208872 | 12420887 | 3 | 201405 | 0 | ||
| 124208872 | 12420887 | 4 | 20151001 | 20151015 | 0 | |
| 124208872 | 12420887 | 5 | 20151001 | 20151015 | 0 | |
| 124208872 | 12420887 | 6 | 20151001 | 0 | ||
| 124208872 | 12420887 | 7 | 20151001 | 20151015 | 0 | |
| 124208872 | 12420887 | 8 | 20151001 | 0 | ||
| 124208872 | 12420887 | 9 | 20151001 | 20151015 | 0 | |
| 124208872 | 12420887 | 10 | 20151001 | 0 | ||
| 124208872 | 12420887 | 11 | 20151001 | 0 |